PureTech Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017
Revenue	15.62	17.39	11.77	9.81	20.75	2.54
Revenue Growth (YoY)	-10.18%	47.76%	20.00%	-52.73%	718.46%	-
Gross Profit	15.62	17.39	11.77	9.81	20.75	2.54
Selling, General & Admin	60.99	57.2	49.44	59.36	47.37	46.28
Research & Development	152.43	110.47	81.86	85.85	77.4	71.67
Operating Expenses	213.42	167.67	131.3	145.21	124.77	117.96
Operating Income	-197.81	-150.28	-119.53	-135.4	-104.02	-115.42
Other Expense / Income	-91.73	-93.48	-139.92	-668.95	-62.59	-146.28
Pretax Income	-106.07	-56.8	20.39	533.55	-41.43	30.86
Income Tax	-55.72	3.76	14.4	112.41	2.22	4.38
Net Income	-50.35	-60.56	5.99	421.14	-43.65	26.47
Net Income Growth	-	-	-98.58%	-	-	-
Shares Outstanding (Basic)	288	286	286	286	-	-
Shares Change	0.67%	0.05%	-	-	-	-
EPS (Basic)	-1.80	-2.10	0.20	14.90	-1.60	1.10
EPS (Diluted)	-1.80	-2.10	0.20	14.40	-1.60	1.10
EPS Growth	-	-	-98.61%	-	-	-
Free Cash Flow	-180.97	-163.82	-137	-110.29	-77.04	-90.78
Free Cash Flow Per Share	-6.29	-5.73	-4.79	-3.86	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-1266.53%	-864.29%	-1015.73%	-1380.64%	-501.34%	-4553.06%
Profit Margin	-322.41%	-348.27%	50.86%	4294.32%	-210.40%	1044.26%
Free Cash Flow Margin	-1158.71%	-942.12%	-1164.15%	-1124.65%	-371.29%	-3580.91%
Effective Tax Rate	-	-	70.64%	21.07%	-	14.21%
EBITDA	-97.18	-49.52	27.03	540.22	-38.66	32.95
EBITDA Margin	-622.23%	-284.77%	229.70%	5508.49%	-186.31%	1299.96%
Depreciation & Amortization	8.89	7.29	6.65	6.67	2.78	2.1
EBIT	-106.07	-56.8	20.39	533.55	-41.43	30.86
EBIT Margin	-679.17%	-326.67%	173.23%	5440.53%	-199.70%	1217.16%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).